TFX - Teleflex Incorporated
NYSE
->
Healthcare
->
Medical Instruments & Supplies
Wayne,
United States
Type: Equity
TFX price evolution
TFX
| (in millions $) | 29 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $238.57 | $237.42 | $222.85 | |
| Short term investments | ||||
| Net receivables | $470.26 | $448.9 | $448.53 | $443.47 |
| Inventory | $639.94 | $636.91 | $627.87 | $626.22 |
| Total current assets | $1499.3 | $1438.09 | $1433.61 | $1407.41 |
| Long term investments | ||||
| Property, plant & equipment | $625.12 | $604.01 | $598.1 | $603.43 |
| Goodwill & intangible assets | $5272.55 | $5327.8 | $5416.02 | |
| Total noncurrent assets | $6003.55 | $6044.31 | $6125.14 | |
| Total investments | ||||
| Total assets | $7486.29 | $7441.64 | $7477.92 | $7532.55 |
| Current liabilities | ||||
| Accounts payable | $119.25 | $113.45 | $115.94 | $132.25 |
| Deferred revenue | ||||
| Short long term debt | $93.75 | $90.63 | $87.5 | |
| Total current liabilities | $618.75 | $556.75 | $571.01 | $606.75 |
| Long term debt | $1661.55 | $1726.79 | $1667.9 | $1838.87 |
| Total noncurrent liabilities | $2326.17 | $2403.7 | $2484.81 | |
| Total debt | $1820.54 | $1862.9 | $1926.37 | |
| Total liabilities | $3004.57 | $2882.92 | $2974.71 | $3091.56 |
| Shareholders' equity | ||||
| Retained earnings | $4268.26 | $4173.05 | $4109.02 | $4109.74 |
| Other shareholder equity | -$258.24 | -$279.2 | -$261.05 | -$314.4 |
| Total shareholder equity | $4558.72 | $4503.21 | $4440.99 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $222.85 | $292.03 | $445.08 | $375.88 |
| Short term investments | ||||
| Net receivables | $443.47 | $408.83 | $383.57 | $395.07 |
| Inventory | $626.22 | $578.51 | $477.64 | $513.2 |
| Total current assets | $1407.41 | $1410.98 | $1429.12 | $1422.42 |
| Long term investments | ||||
| Property, plant & equipment | $603.43 | $578.42 | $573.41 | $574.55 |
| Goodwill & intangible assets | $5416.02 | $4842.9 | $4793.27 | $5105.71 |
| Total noncurrent assets | $6125.14 | $5517.08 | $5442.6 | $5730.13 |
| Total investments | ||||
| Total assets | $7532.55 | $6928.06 | $6871.72 | $7152.56 |
| Current liabilities | ||||
| Accounts payable | $132.25 | $126.81 | $118.24 | $102.52 |
| Deferred revenue | ||||
| Short long term debt | $87.5 | $87.5 | $110 | $100.5 |
| Total current liabilities | $606.75 | $581.49 | $680.12 | $540.03 |
| Long term debt | $1838.87 | $1624.02 | $1856.13 | $2463.99 |
| Total noncurrent liabilities | $2484.81 | $2324.6 | $2436.86 | $3276.07 |
| Total debt | $1926.37 | $1831.96 | $1966.13 | $2564.49 |
| Total liabilities | $3091.56 | $2906.09 | $3116.97 | $3816.1 |
| Shareholders' equity | ||||
| Retained earnings | $4109.74 | $3817.3 | $3517.95 | $3096.23 |
| Other shareholder equity | -$314.4 | -$403.52 | -$346.96 | -$297.3 |
| Total shareholder equity | $4440.99 | $4021.97 | $3754.75 | $3336.46 |
| (in millions $) | 29 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $764.38 | $749.69 | $737.85 | $773.91 |
| Cost of revenue | $333.23 | $321.71 | $342.49 | |
| Gross Profit | $430.17 | $416.46 | $416.13 | $431.42 |
| Operating activities | ||||
| Research & development | $41.09 | $37.3 | $35.86 | |
| Selling, general & administrative | $250.63 | $242.83 | $260.65 | |
| Total operating expenses | $285.98 | $299.58 | $420.93 | $353.4 |
| Operating income | $116.88 | -$4.79 | $78.02 | |
| Income from continuing operations | ||||
| EBIT | $118.54 | -$3.58 | $85.69 | |
| Income tax expense | $19.63 | $17.33 | -$41.55 | $28.79 |
| Interest expense | -$18.76 | $21.17 | $22.68 | $25.79 |
| Net income | ||||
| Net income | $111 | $80.04 | $15.29 | $31.11 |
| Income (for common shares) | $80.04 | $15.29 | $31.11 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2974.49 | $2791.04 | $2537.16 | |
| Cost of revenue | $1327.56 | $1259.95 | $1212.28 | |
| Gross Profit | $1646.93 | $1531.09 | $1324.87 | |
| Operating activities | ||||
| Research & development | $154.35 | $153.82 | $119.75 | |
| Selling, general & administrative | $929.87 | $863.75 | $743.57 | |
| Total operating expenses | $1145.07 | $1037.87 | $901.81 | |
| Operating income | $501.87 | $493.22 | $423.07 | |
| Income from continuing operations | ||||
| EBIT | $517.85 | $500.41 | $423.75 | |
| Income tax expense | $76.44 | $83 | $21.93 | |
| Interest expense | $85.08 | $54.26 | $66.49 | |
| Net income | ||||
| Net income | $356.33 | $363.14 | $335.32 | |
| Income (for common shares) | $356.33 | $363.14 | $335.32 | |
| (in millions $) | 29 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $80.04 | $15.29 | $31.11 | |
| Operating activities | ||||
| Depreciation | $68.13 | $66.04 | $64.2 | |
| Business acquisitions & disposals | -$0.07 | -$588.72 | ||
| Stock-based compensation | $8.61 | $7.13 | $9.33 | |
| Total cash flows from operations | $91.31 | $110.98 | $138.86 | |
| Investing activities | ||||
| Capital expenditures | -$34.8 | -$38.43 | -$27.67 | |
| Investments | $4.57 | $13.7 | $52.86 | |
| Total cash flows from investing | -$76.27 | -$30.23 | -$24.81 | -$563.53 |
| Financing activities | ||||
| Dividends paid | -$47.81 | -$16.02 | -$16 | -$15.98 |
| Sale and purchase of stock | $0.65 | $1.75 | $4.66 | |
| Net borrowings | -$41.13 | -$57.13 | -$223.13 | |
| Total cash flows from financing | -$302.81 | -$56.54 | -$71.45 | -$237.5 |
| Effect of exchange rate | $0.73 | -$3.39 | -$0.15 | $3.52 |
| Change in cash and equivalents | $54.92 | $1.14 | $14.57 | -$658.65 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $356.33 | $363.14 | $485.37 | $335.32 |
| Operating activities | ||||
| Depreciation | $242.12 | $230.59 | $237.36 | $227.25 |
| Business acquisitions & disposals | -$588.92 | -$186 | $220.32 | -$766.43 |
| Stock-based compensation | $31.46 | $27.22 | $22.94 | $20.74 |
| Total cash flows from operations | $510.64 | $342.14 | $651.42 | $436.41 |
| Investing activities | ||||
| Capital expenditures | -$91.44 | -$79.19 | -$71.62 | -$90.69 |
| Investments | $59.13 | $5.78 | $8.04 | $19.34 |
| Total cash flows from investing | -$621.23 | -$257.94 | $156.74 | -$837.78 |
| Financing activities | ||||
| Dividends paid | -$63.9 | -$63.79 | -$63.65 | -$63.22 |
| Sale and purchase of stock | $5.19 | -$4.31 | $23.55 | $18.99 |
| Net borrowings | $101.25 | -$140.25 | -$634.5 | $575 |
| Total cash flows from financing | $38.54 | -$217.51 | -$715.82 | $455.16 |
| Effect of exchange rate | $2.86 | -$19.74 | -$23.13 | $21.01 |
| Change in cash and equivalents | -$69.19 | -$153.05 | $69.2 | $74.8 |
News
Fundamentals
| Market cap | $8.11B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 46.44M |
| Revenue | $3.03B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $237.44M |
| Revenue Q/Q | 2.84% |
| Revenue Y/Y | 3.51% |
| P/E ratio | 34.15 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 2.68 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $5.11 |
|---|---|
| ROA | 3.17% |
| ROE | N/A |
| Debt/Equity | 0.70 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.42 |
| Quick ratio | 1.39 |